Related Experiment Video
Updated: Aug 19, 2026

Visualizing Genetic Variants, Short Targets, and Point Mutations in the Morphological Tissue Context with an RNA In Situ Hybridization Assay
Published on: August 14, 2018
Iterative microarray and RNA interference-based interrogation of the SRC-induced invasive phenotype
Rosalyn B Irby1, Renae L Malek, Greg Bloom
1Department of Surgery, H. Lee Moffit Cancer Center & Research Institute, College of Medicine, University of South Florida, Tampa, Florida 33612, USA.
Abstract:
Src kinase has long been recognized as a factor in the progression of colorectal cancer and seems to play a specific role in the development of the metastatic phenotype. In spite of numerous studies conducted to elucidate the exact role of Src in cancer progression, downstream targets of Src remain poorly understood. Gene expression profiling has permitted the identification of large sets of genes that may be functionally interrelated but it is often unclear as to which molecular pathways they belong. Here we have developed an iterative approach to experimentally reconstruct a network of gene activity regulated by Src and contributing to the invasive phenotype. Our strategy uses a combination of phenotypic anchoring of gene expression profiles and loss-of-function screening by way of RNA-mediated interference. Using a panel of human colon cancer cell lines exhibiting differential Src-specific activity and invasivity, we identify the first two levels of gene transcription responsible for the invasive phenotype, where first-tier genes are controlled by Src activity and the second-tier genes are under the influence of the first tier. Specifically, perturbation of first-tier gene activity by either pharmacologic inhibition of Src or RNA-mediated interference-directed knockdown leads to a loss of invasivity and decline of second-tier gene activity. The targeting of first-tier genes may be bypassed altogether because knockdown of second-tier genes led to a similar loss of invasive potential. In this manner, numerous members of a "transcriptional cascade" pathway for metastatic activity have been identified and functionally validated.
Insights
Src kinase (Src) drives colorectal cancer metastasis by regulating a gene network. Researchers identified key "first-tier" and "second-tier" genes in this Src-regulated cascade, revealing new therapeutic targets for cancer invasion.
Area of Science:
- Molecular Oncology
- Cancer Metastasis Research
- Gene Regulatory Networks
Background:
- Src kinase is implicated in colorectal cancer progression and metastasis.
- Downstream targets and molecular pathways regulated by Src in cancer remain poorly understood.
- Gene expression profiling identifies gene sets but often lacks pathway context.
Purpose of the Study:
- To experimentally reconstruct a gene activity network regulated by Src kinase.
- To identify molecular targets contributing to the invasive phenotype in colorectal cancer.
- To elucidate the hierarchical gene regulation driven by Src activity.
Main Methods:
- Utilized an iterative approach combining phenotypic anchoring of gene expression profiles.
- Employed loss-of-function screening using RNA-mediated interference (RNAi).
- Analyzed human colon cancer cell lines with varying Src activity and invasivity.
Main Results:
- Identified two tiers of gene transcription responsible for the invasive phenotype.
- First-tier genes are directly controlled by Src activity; second-tier genes are influenced by first-tier genes.
- Inhibition of Src or knockdown of first/second-tier genes significantly reduced invasivity and downstream gene activity.
Conclusions:
- Src kinase regulates a 'transcriptional cascade' pathway critical for colorectal cancer metastasis.
- Numerous members of this cascade have been identified and functionally validated as key regulators of invasion.
- Targeting identified first-tier or second-tier genes represents a potential therapeutic strategy to inhibit cancer spread.
Related Concept Videos
Experimental RNAi
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...

